Moderna Inc. has a roadmap in hand for the next few years, which CFO Jamey Mock says should lead the company to financial breakeven in 2026.
The Cambridge drugmaker (Nasdaq: MRNA) laid out its plans for growing beyond its reputation as a Covid-19 vaccine maker in its presentation at the J.P. Morgan Healthcare Conference Monday afternoon.
STAY IN THE KNOW
 |
Watch NBC10 Boston news for free, 24/7, wherever you are. |
 |
Get Boston local news, weather forecasts, lifestyle and entertainment stories to your inbox. Sign up for NBC Boston’s newsletters. |
More on this story from Boston Business Journal
Get top local stories in Boston delivered to you every morning. Sign up for NBC Boston's News Headlines newsletter.
Copyright Boston Business Journal
